Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?

被引：75
作者：
Gauci, Marie-Lea [1 ,2 ]
Baroudjian, Barouyr [1 ,2 ]
Zeboulon, Charlotte [1 ,2 ]
Pages, Cecile [1 ,2 ]
Pote, Nicolas [3 ,4 ]
Roux, Olivier [5 ]
Bouattour, Mohamed [6 ]
Lebbe, Celeste [1 ,2 ]
机构：
[1] Hop St Louis, AP HP, Dept Dermatol, Paris, France
[2] Univ Paris Diderot Paris VII, Sorbonne Paris Cite, INSERM U976, Paris, France
[3] Hop Beaujon, AP HP, Dept Anatomopathol, Clichy, France
[4] Univ Paris Diderot Paris VII, Sorbonne Paris Cite, INSERM UMR 1149, Paris, France
[5] Hop Beaujon, AP HP, Dept Hepatol & Reanimat Hepat, Clichy, France
[6] Hop Beaujon, AP HP, Dept Oncol Digest, 100 Blvd Gen Leclerc, F-92110 Clichy, France
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 69卷 / 02期
关键词：
IPILIMUMAB; NIVOLUMAB;
D O I：
10.1016/j.jhep.2018.03.034
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：548 / 550
页数：4
相关论文
共 50 条
  • [31] Fulminant hepatitis as an immune-related adverse event after nivolumab treatment
    Inamori, Osamu
    Miyagawa-Hayashino, Aya
    Ueno, Akihisa
    Hongo, Fumiya
    Sonobe, Yuta
    Hojo, Tomohito
    Konishi, Eiichi
    PATHOLOGY INTERNATIONAL, 2019, 69 (07) : 434 - 436
  • [32] Immune-related adverse events secondary to immunotherapy in oncology A guide for general practice
    Yeoh, Hui-Ling
    Freilich, Karen
    Voskoboynik, Mark
    Moore, Maggie
    Andrews, Miles C.
    Shackleton, Mark
    Haydon, Andrew M.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2023, 52 (06) : 378 - 385
  • [33] Challenge of Rechallenge: When to Resume Immunotherapy Following an Immune-Related Adverse Event
    Nakajima, Erica C.
    Lipson, Evan J.
    Brahmer, Julie R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (30) : 2714 - +
  • [34] Efficacy and safety of mycophenolate mofetil in treating immune-related hepatitis induced by immune checkpoint inhibitor use: A retrospective study
    Kadokawa, Yukio
    Inoue, Satoko
    Tatsumi, Akitoshi
    Uchida, Mayako
    Fujita, Keiko
    Takagi, Mari
    Inoue, Takako
    Ohe, Shuichi
    Nakai, Yasutomo
    Otsuka, Tomoyuki
    Abe, Yutaro
    Nakabori, Tasuku
    Isei, Taiki
    Kumagai, Toru
    Nishimura, Kazuo
    Ohkawa, Kazuyoshi
    JGH OPEN, 2023, 7 (02): : 87 - 97
  • [35] Sequelae of immunotherapy Checkpoint inhibitor-induced immune-related adverse events
    Duong, Sophie L.
    Zierold, Sarah
    Kramer, Rafaela
    Reincke, Martin
    Kerl-French, Katrin
    Boehmerle, Wolfgang
    Pavel, Marianne
    Weckbach, Ludwig
    French, Lars E.
    Knauss, Samuel
    Heinzerling, Lucie
    ONKOLOGE, 2021, 27 (08): : 739 - 746
  • [36] Immune-related Neutropenia Following Treatment With Immune Checkpoint Inhibitors
    Finkel, Inbar
    Sternschuss, Michal
    Wollner, Mira
    Shamai, Sivan
    Peled, Nir
    Turgeman, Ilit
    Shochat, Tzippy
    Dudnik, Elizabeth
    JOURNAL OF IMMUNOTHERAPY, 2020, 43 (02) : 67 - 74
  • [37] Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
    Postow, Michael A.
    Sidlow, Robert
    Hellmann, Matthew D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02) : 158 - 168
  • [38] Immune-related encephalitis after immune checkpoint inhibitor therapy
    Buckley, Monica W.
    Balaji Warner, Aanika
    Brahmer, Julie
    Cappelli, Laura C.
    Sharfman, William H.
    Fuchs, Ephraim
    Kang, Hyunseok
    Forde, Patrick M.
    Gladstone, Douglas E.
    Ambinder, Richard
    Kelly, Ronan J.
    Lipson, Evan J.
    Gojo, Ivana
    Lee, Edward J.
    Johnson, Tory P.
    Saidha, Shiv
    Llinas, Rafael
    Ostrow, Lyle W.
    Naidoo, Jarushka
    Probasco, John C.
    ONCOLOGIST, 2024, 30 (01)
  • [39] Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
    Herrmann, Sandra M.
    Perazella, Mark A.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (08): : 1139 - 1148
  • [40] Immune-Related Adverse Events of the Gastrointestinal System
    Nicolaides, Steven
    Boussioutas, Alex
    CANCERS, 2023, 15 (03)
12345